• 1. Zannad F, McMurray JJ & Krum H et alEplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 2011; 364: 1121.

  • 2. Vizzardi E, D'Aloia A & Giubbini R et alEffect of spironolactone on left ventricular ejection fraction and volumes in patients with class I or II heart failure. Am J Cardiol 2010; 106: 12921296.

    • Search Google Scholar
    • Export Citation
  • 3. Pitt B, Zannad F & Remme WJ et alThe effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999; 341: 709717.

    • Search Google Scholar
    • Export Citation
  • 4. Pitt B, Remme W & Zannad F et alEplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003; 348: 13091321.

    • Search Google Scholar
    • Export Citation
  • 5. Pitt B. Do diuretics and aldosterone receptor antagonists improve ventricular remodeling? J Card Fail 2002; 8: S491S493.

  • 6. Brilla CG, Matsubara LS, Weber KT. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol 1993; 25: 563575.

    • Search Google Scholar
    • Export Citation
  • 7. Zhao J, Li J & Li W et alEffects of spironolactone on atrial structural remodelling in a canine model of atrial fibrillation produced by prolonged atrial pacing. Br J Pharmacol 2010; 159: 15841594.

    • Search Google Scholar
    • Export Citation
  • 8. Falk T, Jonsson L & Olsen LH et alAssociations between cardiac pathology and clinical, echocardiographic and electrocardiographic findings in dogs with chronic congestive heart failure. Vet J 2010; 185: 6874.

    • Search Google Scholar
    • Export Citation
  • 9. Bernay F, Bland JM & Haggstrom J et alEfficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease. J Vet Intern Med 2010; 24: 331341.

    • Search Google Scholar
    • Export Citation
  • 10. Häggström J, Hansson K & Kvart C et alEffects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs. Am J Vet Res 1997; 58: 7782.

    • Search Google Scholar
    • Export Citation
  • 11. Gardner SY, Atkins CE & Rausch WP et alEstimation of 24-h aldosterone secretion in the dog using the urine aldosterone:creatinine ratio. J Vet Cardiol 2007; 9: 17.

    • Search Google Scholar
    • Export Citation
  • 12. Jensen LT. The aminoterminal propeptide of type III procollagen. Studies on physiology and pathophysiology. Dan Med Bull 1997; 44: 7078.

    • Search Google Scholar
    • Export Citation
  • 13. Uusimaa P, Risteli J & Niemela M et alCollagen scar formation after acute myocardial infarction: relationships to infarct size, left ventricular function, and coronary artery patency. Circulation 1997; 96: 25652572.

    • Search Google Scholar
    • Export Citation
  • 14. Klappacher G, Franzen P & Haab D et alMeasuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. Am J Cardiol 1995; 75: 913918.

    • Search Google Scholar
    • Export Citation
  • 15. Stewart JA Jr, Wei CC & Brower GL et alCardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog. J Mol Cell Cardiol 2003; 35: 311319.

    • Search Google Scholar
    • Export Citation
  • 16. Schuller S, Valentin S & Remy B et alAnalytical, physiologic, and clinical validation of a radioimmunoassay for measurement of procollagen type III amino terminal propeptide in serum and bronchoalveolar lavage fluid obtained from dogs. Am J Vet Res 2006; 67: 749755.

    • Search Google Scholar
    • Export Citation
  • 17. Syme HM, Fletcher MG & Bailey SR et alMeasurement of aldosterone in feline, canine and human urine. J Small Anim Pract 2007; 48: 202208.

    • Search Google Scholar
    • Export Citation
  • 18. Bland JM. Clinical measurement. In: An introduction to medical statistics. Oxford, England: Oxford University Press, 2000;268293.

  • 19. Hansson K, Haggstrom J & Kvart C et alLeft atrial to aortic root indices using two-dimensional and M-mode echocardiography in Cavalier King Charles Spaniels with and without left atrial enlargement. Vet Radiol Ultrasound 2002; 43: 568575.

    • Search Google Scholar
    • Export Citation
  • 20. Thomas WP, Gaber CE & Jacobs GJ et alRecommendations for standards in transthoracic two-dimensional echocardiography in the dogs and cat. Echocardiography Committee of the Specialty of Cardiology, American College of Veterinary Internal Medicine. J Vet Intern Med 1993; 7: 247252.

    • Search Google Scholar
    • Export Citation
  • 21. Cornell CC, Kittleson MD & Della Torre P et alAllometric scaling of M-mode cardiac measurements in normal adult dogs. J Vet Intern Med 2004; 18: 311321.

    • Search Google Scholar
    • Export Citation
  • 22. Atkins C, Bonagura J & Ettinger S et alGuidelines for the diagnosis and treatment of canine chronic valvular heart disease. J Vet Intern Med 2009; 23: 11421150.

    • Search Google Scholar
    • Export Citation
  • 23. Haggstrom J, Hansson K & Kvart C et alChronic valvular disease in the Cavalier King Charles Spaniel in Sweden. Vet Rec 1992; 131: 549553.

    • Search Google Scholar
    • Export Citation
  • 24. Sayer MB, Atkins CE & Fujii Y et alAcute effect of pimobendan and furosemide on the circulating renin-angiotensin-aldosterone system in healthy dogs. J Vet Intern Med 2009; 23: 10031006.

    • Search Google Scholar
    • Export Citation
  • 25. Sisson DD. Neuroendocrine evaluation of cardiac disease. Vet Clin North Am Small Anim Pract 2004; 34: 11051126.

  • 26. Pedersen HD, Koch J & Poulsen K et alActivation of the renin-angiotensin system in dogs with asymptomatic and mildly symptomatic mitral valvular insufficiency. J Vet Intern Med 1995; 9: 328331.

    • Search Google Scholar
    • Export Citation
  • 27. Pedersen HD. Effects of mild mitral valve insufficiency, sodium intake, and place of blood sampling on the renin-angiotensin system in dogs. Acta Vet Scand 1996; 37: 109118.

    • Search Google Scholar
    • Export Citation
  • 28. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991; 83: 18491865.

    • Search Google Scholar
    • Export Citation
  • 29. O'Gara P, Sugeng L & Lang R et alThe role of imaging in chronic degenerative mitral regurgitation. JACC Cardiovasc Imaging 2008; 1: 221237.

    • Search Google Scholar
    • Export Citation
  • 30. Atkins CE, Rausch WP & Gardner SY et alThe effect of amlodipine and the combination of amlodipine and enalapril on the renin-angiotensin-aldosterone system in the dog. J Vet Pharmacol Ther 2007; 30: 394400.

    • Search Google Scholar
    • Export Citation
  • 31. Urata H, Kinoshita A & Misono KS et alIdentification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem 1990; 265: 2234822357.

    • Search Google Scholar
    • Export Citation
  • 32. MacFadyen RJ, Lee AF & Morton JJ et alHow often are angiotensin II and aldosterone concentrations raised during chronic ACE inhibitor treatment in cardiac failure? Heart 1999; 82: 5761.

    • Search Google Scholar
    • Export Citation
  • 33. Lopez B, Querejeta R & Gonzalez A et alEffects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure. J Am Coll Cardiol 2004; 43: 20282035.

    • Search Google Scholar
    • Export Citation
  • 34. Sasaguri M, Noda K & Tashiro E et alThe regression of left ventricular hypertrophy by imidapril and the reduction of serum procollagen type III amino-terminal peptide in hypertensive patients. Hypertens Res 2000; 23: 317322.

    • Search Google Scholar
    • Export Citation
  • 35. Leroy V, Monier F & Bottari S et alCirculating matrix metalloproteinases 1, 2, 9 and their inhibitors TIMP-1 and TIMP-2 as serum markers of liver fibrosis in patients with chronic hepatitis C: comparison with PIIINP and hyaluronic acid. Am J Gastroenterol 2004; 99: 271279.

    • Search Google Scholar
    • Export Citation
  • 36. Hochweiss S, Fruchtman S & Hahn EG et alIncreased serum procollagen III aminoterminal peptide in myelofibrosis. Am J Hematol 1983; 15: 343351.

    • Search Google Scholar
    • Export Citation
  • 37. Lee YJ, Shin KC & Kang SW et alType III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis. Clin Exp Rheumatol 2001; 19: 6974.

    • Search Google Scholar
    • Export Citation
  • 38. Zhu GG, Stenback F & Risteli L et alOrganization of type III collagen in benign and malignant ovarian tumors. An immunohistochemical study. Cancer 1993; 72: 16791684.

    • Search Google Scholar
    • Export Citation
  • 39. Young WF Jr. Minireview: primary aldosteronism-changing concepts in diagnosis and treatment. Endocrinology 2003; 144: 22082213.

  • 40. Alpert BS, Bain HH & Balfe JW et alRole of the renin-angiotensin-aldosterone system in hypertensive children with coarctation of the aorta. Am J Cardiol 1979; 43: 828834.

    • Search Google Scholar
    • Export Citation
  • 41. Beevers DG, Maheshwari MB & Ryan PG et alHypertension due to a renin-secreting juxtaglomerular cell tumor. Am J Hypertens 2008; 21: 13591361.

    • Search Google Scholar
    • Export Citation
  • 42. Kuiper JJ, Boomsma F & van Buren H et alComponents of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis. Eur J Clin Invest 2008; 38: 939944.

    • Search Google Scholar
    • Export Citation
  • 43. Schrier RW, Masoumi A, Elhassan E. Aldosterone: role in edematous disorders, hypertension, chronic renal failure, and metabolic syndrome. Clin J Am Soc Nephrol 2010; 5: 11321140.

    • Search Google Scholar
    • Export Citation
  • 44. Freeman LM, Rush JE, Markwell PJ. Effects of dietary modification in dogs with early chronic valvular disease. J Vet Intern Med 2006; 20: 11161126.

    • Search Google Scholar
    • Export Citation
  • 45. Silvestre JS, Robert V & Heymes C et alMyocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J Biol Chem 1998; 273: 48834891.

    • Search Google Scholar
    • Export Citation
  • 46. Weber KT. Aldosteronism revisited: perspectives on less well-recognized actions of aldosterone. J Lab Clin Med 2003; 142: 7182.

  • 47. Rush JE, Freeman LM & Brown DJ et alClinical, echocardiographic, and neurohormonal effects of a sodium-restricted diet in dogs with heart failure. J Vet Intern Med 2000; 14: 513520.

    • Search Google Scholar
    • Export Citation
  • 48. Dukes-McEwan J, French AT, Corcoran BM. Doppler echocardiography in the dog: measurement variability and reproducibility. Vet Radiol Ultrasound 2002; 43: 144152.

    • Search Google Scholar
    • Export Citation

Advertisement

Associations among serum N-terminal procollagen type III concentration, urinary aldosterone-to-creatinine ratio, and ventricular remodeling in dogs with myxomatous mitral valve disease

Melanie J. Hezzell PhD, VetMB1, Adrian Boswood MA, VetMB2, Yu-Mei Chang PhD3, Walasinee Moonarmart DVM, PhD4, and Jonathan Elliott PhD, VetMB5
View More View Less
  • 1 Department of Veterinary Clinical Sciences, Royal Veterinary College, University of London, North Mymms, Hatfield, Hertfordshire, AL9 7TA, England.
  • | 2 Department of Veterinary Clinical Sciences, Royal Veterinary College, University of London, North Mymms, Hatfield, Hertfordshire, AL9 7TA, England.
  • | 3 Department of Veterinary Basic Sciences, Royal Veterinary College, University of London, London, NW1 0TU, England.
  • | 4 Department of Veterinary Clinical Sciences, Royal Veterinary College, University of London, North Mymms, Hatfield, Hertfordshire, AL9 7TA, England.
  • | 5 Department of Veterinary Basic Sciences, Royal Veterinary College, University of London, London, NW1 0TU, England.

Abstract

Objective—To assess relationships among serum N-terminal procollagen type III concentration, urinary aldosterone-to-creatinine concentration ratio (UAC), and clinical variables in dogs with myxomatous mitral valve disease (MMVD) and healthy dogs.

Animals—162 dogs with MMVD and 24 healthy control dogs of comparable age and body weight.

Procedures—Blood and urine samples were collected from each dog. Dogs with MMVD underwent echocardiography and ECG. Ventricular diameter measurements were normalized for body weight. Serum N-terminal procollagen type III and urinary aldosterone concentrations were measured via radioimmunoassay. Each dog was examined on 1 to 3 occasions. Examinations were repeated at approximately 6-month intervals.

Results—Serum N-terminal procollagen type III concentration decreased with increasing severity of MMVD and was negatively associated with age and left ventricular end-diastolic and end-systolic diameters. The UAC increased with prior percentage change in left ventricular end-diastolic diameter per month, subsequent percentage change in left ventricular end-systolic diameter per month, and treatment with diuretics and was negatively associated with age. Both UAC and serum N-terminal procollagen type III concentration were higher in Cavalier King Charles Spaniels than in other breeds when other measured variables were controlled for.

Conclusions and Clinical Relevance—In dogs with MMVD, echocardiographic indicators of left ventricular remodeling appeared to be associated with a decrease in serum concentration of a marker of collagen type III turnover and an increase in urinary aldosterone concentration.

Abstract

Objective—To assess relationships among serum N-terminal procollagen type III concentration, urinary aldosterone-to-creatinine concentration ratio (UAC), and clinical variables in dogs with myxomatous mitral valve disease (MMVD) and healthy dogs.

Animals—162 dogs with MMVD and 24 healthy control dogs of comparable age and body weight.

Procedures—Blood and urine samples were collected from each dog. Dogs with MMVD underwent echocardiography and ECG. Ventricular diameter measurements were normalized for body weight. Serum N-terminal procollagen type III and urinary aldosterone concentrations were measured via radioimmunoassay. Each dog was examined on 1 to 3 occasions. Examinations were repeated at approximately 6-month intervals.

Results—Serum N-terminal procollagen type III concentration decreased with increasing severity of MMVD and was negatively associated with age and left ventricular end-diastolic and end-systolic diameters. The UAC increased with prior percentage change in left ventricular end-diastolic diameter per month, subsequent percentage change in left ventricular end-systolic diameter per month, and treatment with diuretics and was negatively associated with age. Both UAC and serum N-terminal procollagen type III concentration were higher in Cavalier King Charles Spaniels than in other breeds when other measured variables were controlled for.

Conclusions and Clinical Relevance—In dogs with MMVD, echocardiographic indicators of left ventricular remodeling appeared to be associated with a decrease in serum concentration of a marker of collagen type III turnover and an increase in urinary aldosterone concentration.

Contributor Notes

Dr. Moonarmart's present address is Department of Clinical Sciences and Public Health, Faculty of Veterinary Science, Mahidol University, Nakhon Pathom, Thailand.

Laboratory consumables were provided by CEVA Santé Animale, Libourne, France.

Dr. Hezzell's PhD studentship was supported by the Petplan Charitable Trust.

Presented in abstract form at the American College of Veterinary Internal Medicine Forum, Denver, June 2011.

Address correspondence to Dr. Hezzell (mhezzell@vet.upenn.edu).